Pacific Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Pacific Wealth Management's ABBV Position: Q3 2026 in Review
Pacific Wealth Management reduced its AbbVie (ABBV) stake by 0.6% in Q3 2026, selling an estimated $58.7K and leaving 38,039 shares worth $10M. The position accounts for 4.38% of the portfolio, ranked #4.
Pacific Wealth Management first reported a position in ABBV in Q3 2022 and has held it in 17 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Pacific Wealth Management held 38,039 shares of AbbVie worth $10M as of Q3 2026.
- Pacific Wealth Management sold 229 AbbVie shares in Q3 2026, an estimated $58.7K.
- AbbVie made up 4.38% of Pacific Wealth Management's portfolio in Q3 2026, its #4 holding.
- Pacific Wealth Management first reported a position in AbbVie in Q3 2022 and has held it in 17 quarters since.
- 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Pacific Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.